AG0039L3

36791-04-5 | 1-β-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide

AG0039L3

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	36791-04-5
Catalog Number	AG0039L3(AGN-PC-0RCR4W)
Chemical Name	1-β-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
IUPAC Name	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide
InChI	InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1
InChI Key	IWUCXVSUMQZMFG-AFCXAGJDSA-N
MDL Number	MFCD00058564
Molecular Formula	C8H12N4O5
Molecular Weight	244.2047
NSC Number	758650
SMILES	[C@@H]1([C@H](O)[C@H](O)[C@H](O1)CO)N1N=C(N=C1)C(=O)N
UNII	49717AWG6K
Synonyms	ICN 1229, ICN-1229, ICN1229, Rebetol, Ribamide, Ribamidil, Ribamidyl, Ribasphere, Ribavirin, Ribovirin, Tribavirin, Vilona, Viramide, Virazide, Virazole, ribavirin, 36791-04-5, Tribavirin, Rebetol, Virazole, Ribavirine, Copegus, Vilona, Ribamide, Ribamidil, Ribasphere, Viramid, Ribamidyl, Ribavirina, Ribavirinum, Rebetron, Varazid, RTCA, Ribavirin Capsules, Ribavirine [INN-French], Ribavirinum [INN-Latin], ICN-1229, Ribavirina [INN-Spanish], Rebretron, Virazid, Ribav, 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide, 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide, DRG-0028, UNII-49717AWG6K, Ribavirin (Copegus), 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide, HSDB 6513, MFCD00058564, RBV, BRN 0892462, Ravanex, 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-1,2,4-triazole-3-carboxamide, CHEBI:63580, 49717AWG6K, Ribavirin, 98%, 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide, 1-(beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide, 1H-1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-, Ribovirin, Viramide, Virazide, DSSTox_CID_3557, EN300-59237, NSC 163039, DSSTox_RID_77081, DSSTox_GSID_23557, RTC, 1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-, 1-(beta-D-Ribofuranosyl)-1,2,4-triazole-3-carboxamide, Cotronak, Ribacine, Ribavirin [USAN:INN], C-Virin, Ribasphere (TN), Virazole (TN), SMR000058315, Copegus (TN), Rebetol (TN), SR-01000076112, SCH 18908, Ribavirine;, NSC163039, NSC-163039, Ribavirin [USAN:USP:INN:BAN], Drug: Ribavirin, Ribavirin,(S), NCGC00015904-02, AK-49185, Ribavirin, antiviral, CAS-36791-04-5, RG-964, PubChem14187, Ro-20-9963, Spectrum_001826, Virazole (Ribavirin) Inhalation Solution, 4pb1, ribofluranosyl carboxamide, AC1L1XXZ, AC1Q1IDC, AC1Q4ZGS, Prestwick3_000993, Spectrum3_001876, Spectrum4_001252, Spectrum5_002075, R-964, 1-|A-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide, Ro 20-9963/000, R 9644, SCHEMBL3727, CHEMBL1643, Lopac0_001063, BSPBio_001085, BSPBio_003352, KBioGR_001804, KBioSS_002331, cid_37542, MLS000028486, MLS002222317, DivK1c_000782, SPECTRUM1503938, Ribavirin (JP17/USP/INN), BPBio1_001195, GTPL6842, ICN-1229 ,RTCA, 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide, DTXSID8023557, CTK7J7594, HMS502H04, KBio1_000782, KBio2_002328, KBio2_004896, KBio2_007464, KBio3_002854, 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide, BIB6306, IWUCXVSUMQZMFG-AFCXAGJDSA-N, NINDS_000782, HMS2090L15, HMS2094O09, HMS2098G07, HMS2232P07, HMS3263E08, HMS3715G07, Pharmakon1600-01503938, BB_NC-00567, HY-B0434, ZINC1035331, Tox21_110259, Tox21_200967, Tox21_501063, BDBM50154375, CCG-38985, NSC758650, s2504, AKOS001715163, Tox21_110259_1, API0004062, CS-2540, DB00811, GS-3572, LP01063, LS-1241, MCULE-9495128592, NSC-758650, IDI1_000782, SMP1_000261, NCGC00090726-01, NCGC00090726-03, NCGC00090726-04, NCGC00090726-05, NCGC00090726-06, NCGC00090726-07, NCGC00090726-08, NCGC00090726-09, NCGC00090726-12, NCGC00258520-01, NCGC00261748-01, AJ-24715, AS-34178, BR-49185, CC-34249, CPD000058315, SAM002548967, SC-12159, ZB015662, BCP0726000138, SBI-0051033.P003, AB0068936, AX8005387, ST2413783, AB00430481, EU-0101063, FT-0082885, FT-0630597, FT-0649908, R0077, D00423, J10190, M-7546, AB00430481-15, AB00430481-16, AB00430481_17, AB00430481_18, 1-beta-Ribofuranosyl-1,2,4-triazole-3-carboamide, 791R045, C-14783, SR-01000721904, SR-01000076112-2, SR-01000076112-3, SR-01000076112-4, SR-01000721904-2, BRD-K60369935-001-02-7, BRD-K60369935-001-18-3, SR-01000076112-11, 1-?-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide, Ribavirin, British Pharmacopoeia (BP) Reference Standard, Z1522567185, 1-(beta -D-ribofuranosyl)-1,2,4-triazole-3-carboxamide, Ribavirin, European Pharmacopoeia (EP) Reference Standard, Ribavirin, United States Pharmacopeia (USP) Reference Standard, Ribavirin, Pharmaceutical Secondary Standard; Certified Reference Material, 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide, Ribavarin, Ribavirin Mylan, Ribavirin Teva, Mixture Name, Drug: Ribavirin, Ribavirin-TP, Vilona (TN), Ribavirin BioPartners, Ribavirin triphosphate, Interferon / ribavirin, Ribavirin and interferon, Virazole 5'-triphosphate, C8H12N4O5.Unspecified, D0DI8X, D0H3WI, Ribavirin (JAN/USP/INN), Ribavirin Teva Pharma B.V., C8H12N4O5, C8-H12-N4-O5.Unspecified, ICN 1229, EBP 954, ICN1229, Ribavirin, 98% - 25G 25g, CID37542, CIE 1229, C8-H12-N4-O5, CS-O-31017, KS-1104, B2125, RBI034 (2-5A antisense compound) + Ribavirin, AA-504/07617051, D012254, 1-beta-D-Ribofuranosyl-124-triazol-3-carboxyamide, 1-beta-D-Ribofuranosyl-124-triazole-3-carboxamide, 1H-1,2,4-Triazole-3-carboxamide, 1-.beta.-D-ribofuranosyl-, 1-.beta.-D-Ribofuranosyl-1,2,4-triazol-3-carboxiamida, 1h-1,2,4-triazole-3-carboxamide, 1--d-ribofuranosyl-, 1H-1,2,4-triazol-3-carboxamida, 1-beta-D-ribofuranosil-, 252269-50-4, RTP,

Complexity	304
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	4
Defined Bond Stereocenter Count	0
Exact Mass	244.081g/mol
Formal Charge	0
Heavy Atom Count	17
Hydrogen Bond Acceptor Count	7
Hydrogen Bond Donor Count	4
Isotope Atom Count	0
Molecular Weight	244.207g/mol
Monoisotopic Mass	244.081g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	144A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	-1.8

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H360
Packing Group
Precautionary statements	P201-P308+P313-P280-P202-P405-P501
UN Code

Certificate of Analysis

Lot Number